miR‐181a/b therapy in lung cancer: reality or myth?

Author:

Braicu Cornelia1,Gulei Diana2,Cojocneanu Roxana1,Raduly Lajos1,Jurj Ancuta1,Knutsen Erik3,Calin George Adrian34,Berindan‐Neagoe Ioana125

Affiliation:

1. Research Center for Functional Genomics, Biomedicine and Translational Medicine ‘Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj‐Napoca Romania

2. MedFuture Research Center for Advanced Medicine ‘Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj‐Napoca Romania

3. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston TX USA

4. Center for RNA Inference and Non‐Coding RNA The University of Texas MD Anderson Cancer Center Houston TX USA

5. Department of Functional Genomics and Experimental Pathology The Oncology Institute ‘Prof. Dr. Ion Chiricuta’ Cluj‐Napoca Romania

Funder

National Institutes of Health

National Cancer Institute

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3